Blood antioxidant status and urinary levels of catecholamine metabolites in beta-thalassemia.
It has been reported that iron overload in beta-thalassemia leads to an enhanced generation of reactive oxygen species and to oxidative stress. We have studied the oxidant/antioxidant imbalance in the blood of 48 transfusion-dependent beta-thalassemic patients (TLP) (17 males, 31 females, 11-22 year), under chelation therapy, and in 40 sex and age matched healthy controls (CTR). Plasma and lymphocyte levels of vitamin E (Vit E), ubiquinol (CoQ10H2), ubiquinone (CoQ10), plasma concentrations of vitamin A (Vit A), beta-carotene, lycopene, vitamin C (Vit C), total thiols, fatty acid patterns of phospholipids (PL-FA), and plasma and urinary markers of lipoperoxidation (TBA-RM, conjugated dienes, and azelaic acid (AZA), as well as the urinary levels of catecholamine and serotonin metabolites, were evaluated by gas chromatography-mass spectrometry (GC-MS), HPLC and spectrophotometry. Routine laboratory blood analyses were performed on the same samples; 39/48 TLP were HCV positive. Blood samples were collected just before transfusion, the 24 h urine samples the day before. Our results clearly showed that a severe oxidative stress occurs in the plasma of TLP in comparison with CTR. In fact, the levels of lipophilic antioxidants and ascorbate were severely depleted: CoQ10H2 (-62.5%), total CoQ10 (-35.1%), Vit E (-43.8%), beta-carotene (-31.1%), lycopene (-63.7%), Vit A (-35.9%), Vit C (-23.1%). The impairment of the antioxidant status was associated with elevated plasma levels of by-products of lipoperoxidation and urinary concentrations of catecholamine metabolites and of AZA, indicating a high degree of both neurological stress and lipoperoxidation. A significant positive correlation was found between vitamin E and non-transferrin-bound iron (NTBI) (r = -0.81; p < 0.001), while no correlation was found between antioxidant depletion and ferritin serum levels, average blood consumption, or the presence of clinical complications. The administration of selective antioxidants along with an appropriate diet might represent a promising way of counteracting oxidative damage and its deleterious effects on the progression of the disease.
De Luca
C
C
Istituto Dermapatico dell'Immacolata (IRCCS), Centro Invecchiamento Cellulare, Rome, Italy. c.deluca@idi.it
Filosa
A
A
Grandinetti
M
M
Maggio
F
F
Lamba
M
M
Passi
S
S
D000293:Adolescent; D000328:Adult; D000975:Antioxidants / Q000032:analysis*; D001663:Bilirubin / Q000097:blood; D002338:Carotenoids / Q000097:blood; D002395:Catecholamines / Q000378:metabolism / Q000652:urine*; D002648:Child; D005227:Fatty Acids / Q000097:blood / Q000378:metabolism; D005260:Female; D005293:Ferritins / Q000097:blood; D006801:Humans; D007501:Iron / Q000097:blood; D015227:Lipid Peroxidation; D008297:Male; D018384:Oxidative Stress; D012701:Serotonin / Q000378:metabolism / Q000652:urine; D013438:Sulfhydryl Compounds / Q000097:blood; D014451:Ubiquinone / Q000031:analogs & derivatives / Q000097:blood; D014527:Uric Acid / Q000097:blood; D014815:Vitamins / Q000097:blood; D017086:beta-Thalassemia / Q000097:blood / Q000378:metabolism* / Q000652:urine
D000975:Antioxidants; D002395:Catecholamines; D005227:Fatty Acids; D013438:Sulfhydryl Compounds; D014815:Vitamins; D014451:Ubiquinone; D014527:Uric Acid; D012701:Serotonin; D002338:Carotenoids; D005293:Ferritins; D007501:Iron; D001663:Bilirubin